1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
161.63%
Net income growth above 1.5x ENPH's 24.63%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-11.90%
Both reduce yoy D&A, with ENPH at -14.27%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-100.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-71.67%
Both cut yoy SBC, with ENPH at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-365.95%
Both reduce yoy usage, with ENPH at -35.74%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
59.85%
AR growth is negative or stable vs. ENPH's 393.24%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-4.46%
Both reduce yoy inventory, with ENPH at -238.19%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-40.54%
Both negative yoy AP, with ENPH at -31.38%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-589.33%
Negative yoy usage while ENPH is 23.70%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
111.65%
Lower 'other non-cash' growth vs. ENPH's 4372.11%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-431.41%
Both yoy CFO lines are negative, with ENPH at -45.00%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-63.82%
Negative yoy CapEx while ENPH is 43.46%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
62.75%
Some yoy expansion while ENPH is negative at -42.29%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
11.99%
We have some liquidation growth while ENPH is negative at -27.60%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-43.93%
We reduce yoy other investing while ENPH is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
36.96%
We have mild expansions while ENPH is negative at -145.27%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Issuance growth of 100.00% while ENPH is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.